Tevogen Bio Holdings Inc (NASDAQ: TVGN) is 8.74% higher on its value in year-to-date trading and has touched a low of $0.26 and a high of $21.09 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TVGN stock was last observed hovering at around $1.06 in the last trading session, with the day’s gains setting it 0.06%.
Currently trading at $1.12, the stock is 9.28% and -23.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.55 million and changing 5.66% at the moment leaves the stock -3.97% off its SMA200. TVGN registered -89.86% loss for a year compared to 6-month gain of 60.00%. The firm has a 50-day simple moving average (SMA 50) of $1.45558 and a 200-day simple moving average (SMA200) of $1.166275.
The stock witnessed a -5.08% loss in the last 1 month and extending the period to 3 months gives it a 267.70%, and is 6.67% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.26% over the week and 11.24% over the month.
Tevogen Bio Holdings Inc (TVGN) has around 17 employees, a market worth around $207.16M and $0.00M in sales. Distance from 52-week low is 338.18% and -94.69% from its 52-week high.
.
Tevogen Bio Holdings Inc (TVGN) Top Institutional Holders
The shares outstanding are 170.77M, and float is at 24.92M with Short Float at 4.72%.
Tevogen Bio Holdings Inc (TVGN) Insider Activity
The most recent transaction is an insider sale by Flomenberg Neal. SEC filings show that Flomenberg Neal sold 1,078,600 shares of the company’s common stock on Oct 17 ’24 at a price of $1.62 per share for a total of $1.75 million. Following the sale, the insider now owns 4.25 million shares.
Tevogen Bio Holdings Inc disclosed in a document filed with the SEC on Jun 12 ’24 that Desai Kirti (Chief Financial Officer) bought a total of 3,000 shares of the company’s common stock. The trade occurred on Jun 12 ’24 and was made at $0.82 per share for $2460.0. Following the transaction, the insider now directly holds 9.7 million shares of the TVGN stock.
Still, SEC filings show that on Jun 05 ’24, Saadi Ryan H. (Chief Executive Officer) acquired 2,607 shares at an average price of $0.77 for $2000.0. The insider now directly holds 118,252,659 shares of Tevogen Bio Holdings Inc (TVGN).
